Ajanta Pharma receives final approval for Aripiprazole Tablets
From USFDA
Ajanta Pharma has received final approval for Aripiprazole Tablets (2mg, 5 mg, 10mg, 15mg, 20mg, 30mg), the bioequivalent generic of Abilify from USFDA. Ajanta Pharma US Inc, a wholly owned subsidiary, will be launching the product into the US market soon.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content